Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$19.84 +0.48 (+2.48%)
As of: Oct 20, 2026 · 3:59 PM EDT

Amneal Pharmaceuticals (AMRX) Cost of Revenue (2017 - 2026)

Updated

Amneal Pharmaceuticals' Cost of Revenue came in at $461.69 million for Q2 2026, up 5.3% from $438.26 million a year earlier and up 14.7% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Cost of Revenue (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Amneal Pharmaceuticals reported Cost of Revenue of $1.89 billion, up 6.4% year-over-year; for FY2025, it was $1.91 billion, up 7.4% from FY2024.

  • Cost of Revenue has increased in each of the last four years, with a five-year compound annual growth rate of 7.5% (FY2020 to FY2025).
  • Going back by year, Cost of Revenue was $1.77 billion in FY2024 (+12.7%), $1.57 billion in FY2023 (+10.2%), $1.43 billion in FY2022 (+7.8%) and $1.32 billion in FY2021 (-0.4%).
  • The five-year range for quarterly Cost of Revenue is $323.06 million (Q1 2022) to $517.13 million (Q4 2025).
  • Year-over-year, Cost of Revenue increased in six of the last eight quarters, with growth averaging 6.0%.
  • The fastest year-over-year change in Cost of Revenue over five years came in Q2 2024 (growth of 19.2%), and the weakest in Q1 2026 (a decline of 8.4%).
  • Business Quant data shows AMRX's Cost of Revenue at $402.41 million (Q1 2026), $517.13 million (Q4 2025) and $510.54 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 8.05 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 4.29 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 2.52 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 4.09 Bn
10 Amneal Pharmaceuticals 6.34 Bn 5.53 Bn 334.51 Mn 461.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 461.69 Mn
Mar 31, 2026 402.41 Mn
Dec 31, 2025 517.13 Mn
Sep 30, 2025 510.54 Mn
Jun 30, 2025 438.26 Mn
Mar 31, 2025 439.53 Mn
Dec 31, 2024 467.65 Mn
Sep 30, 2024 432.91 Mn
Jun 30, 2024 451.83 Mn
Mar 31, 2024 421.13 Mn
Dec 31, 2023 427.15 Mn
Sep 30, 2023 387.51 Mn
Jun 30, 2023 379.03 Mn
Mar 31, 2023 379.35 Mn
Dec 31, 2022 394.37 Mn
Sep 30, 2022 351.33 Mn
Jun 30, 2022 358.84 Mn
Mar 31, 2022 323.06 Mn
Dec 31, 2021 371.18 Mn
Sep 30, 2021 329.39 Mn
API Access

Amneal Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AMRX&period=max&api_key=YOUR_API_KEY